DEF 14A: Axon Enterprise Aims to Cut Gun Deaths by 50% with New Tech, Eyes Expansion

Sentiment:

Proxy Statement 29 March 2024 3:56 PM

Axon Enterprise reports record revenue and net income in 2023, driven by growth in cloud services and new product adoption, while setting ambitious goals for reducing gun-related deaths and expanding its technology ecosystem.

Summary

Axon Enterprise achieved record revenue of $1.56 billion in 2023, marking a 31% increase from the previous year.
Net income reached $174 million, resulting in an 11.1% net income margin.
Adjusted EBITDA was $329 million, representing a 21.1% Adjusted EBITDA margin.
Axon Cloud and Services revenue grew by 52% in 2023, accelerating from 50% the year before.
The company's TASER business saw a 15% growth, while Sensors experienced a 34% increase.
Axon aims to cut gun-related deaths between police and the public in the United States by 50% over 10 years.
The company launched the new TASER 10 with a 45-foot range and a 10-shot magazine.
Axon acquired Sky-Hero, a provider of tactical drones and robots.
The company launched the Axon National Gun Fatality Database and the TASER Research and Development (TREND) program.
Axon is launching the Apollo Alliance, a cohort of partner agencies deploying TASER 10, VR, and data sharing programs.
The company's initial outlook for 2024 contemplates over 20% revenue growth and Adjusted EBITDA margin expansion.
Axon continues to target a 20% or greater compound annual growth rate over the longer term.

Sentiment

Score: 8

Explanation: The document expresses a positive outlook with record financial results and ambitious goals for the future. While acknowledging global challenges, the tone is optimistic and confident in the company's ability to drive positive change.

Positives

Record revenue and net income in 2023 demonstrate strong financial performance.
Significant growth in Axon Cloud and Services revenue indicates increasing adoption of subscription-based offerings.
Launch of new products like TASER 10 and Axon Body 4 fuels growth in respective business segments.
Ambitious goal to reduce gun-related deaths showcases commitment to social impact.
Strategic acquisitions like Sky-Hero expand product offerings and capabilities.
Initiatives like the Axon National Gun Fatality Database and Apollo Alliance demonstrate a focus on data-driven solutions.
Positive outlook for 2024 with expected revenue growth and margin expansion.

Risks

The document mentions global humanitarian crises and violence, which could impact the company's operations or reputation.
Achieving the moonshot goal of cutting gun-related deaths by 50% is an ambitious undertaking with inherent challenges.
The company's reliance on technology, training, and data sharing programs may face obstacles in implementation and adoption.
The company's expansion into new categories, such as robotics and AI, involves risks associated with innovation and market acceptance.

Future Outlook

The company's initial outlook for 2024 contemplates over 20% revenue growth and Adjusted EBITDA margin expansion, and it continues to target a 20% or greater compound annual growth rate over the longer term.

Management Comments

I believe we are strongest when we use lethality most sparingly; when we use all other tools at our disposal to reduce the loss of life wherever possible.
We seek to use technology to fight violence, to find new ways to stop violence, and to reduce the effects of violence where it does occur.
We also seek to hold those who commit violence to accounttechnology can give us new solutions that elevate the goals of every human and every society to live in safety and security.

Industry Context

Axon's focus on technology solutions for law enforcement aligns with the broader trend of digital transformation in the public safety sector, where agencies are increasingly adopting cloud-based software, body-worn cameras, and data analytics to improve efficiency, transparency, and community relations.

Comparison to Industry Standards

The document mentions a peer comparator group for executive compensation, including companies like Alarm.com, Fair Isaac Corporation, and HubSpot, suggesting that Axon benchmarks its compensation practices against other technology companies with similar revenue and market capitalization.
The document notes that Axon's five-year share performance ranks in the 99th percentile of all S&P 500 companies, indicating strong relative performance compared to a broad market index.
The document also states that Axon's three-, five-, and 10-year total shareholder returns rank in the 98th, 96th, and 96th percentile among the compensation peer group, respectively, suggesting that Axon's long-term shareholder returns are competitive within its industry.

Corporate Governance

Change Type	Description	Effective Date	Impact Assessment
Director Service Policy	The Board of Directors recognizes the time commitment that service on a board of directors requires, as well as other commitments applicable to the Companys directors. In 2023, the Board updated its Corporate Governance Guidelines to establish limits on the number of boards on which our directors may serve.	2023	A director who is not a named executive officer of a public company may serve on a total of four public company boards, including the Companys Board. A director who is also a named executive officer of a public company may serve on a total of two public company boards, including the Companys Board.
Board Refreshment; Tenure and Term Limits	The Board values the contributions of both newer perspectives as well as directors who have developed, over a period of time, an increased understanding of, and insight into, the governance and business of the Company and the issues confronting it. In 2023, three directors joined the Companys Board of Directors. To further our commitment to ensuring meaningful Board refreshment, in 2023, the Board updated its Corporate Governance Guidelines to implement formal term limits for directors in order to ensure alignment of director qualifications, attributes, skills and experience with the Companys evolving strategy.	2023	Each non-executive director of the Company must submit a letter of resignation to the chair of the NCG Committee upon reaching 20 continuous years of service as a director of the Company or age 72, whichever occurs first, and each year thereafter, which letter of resignation may be accepted or rejected by the Board in its sole discretion.
Adoption of Proxy Access	In 2023, we amended our Bylaws to adopt a proxy access provision, which permits a shareholder, or a group of up to 20 shareholders, who own 3% or more of our voting stock continuously for at least three years, to nominate and include in our annual meeting proxy materials director nominees constituting up to the greater of two directors or 20% of the Board, subject to certain conditions and provided that the shareholder(s) and director nominee(s) satisfy all eligibility, procedural and disclosure requirements specified in our Bylaws, including that each director nominee submitted through the proxy access provisions must meet the qualifications to be an independent director.	2023	This provision is in the best interest of Axon and its shareholders. First, designating a forum in which certain claims can be brought promotes the efficient resolution of such claims and reduces the likelihood of duplicative lawsuits being brought in multiple jurisdictions.
Exclusive Forum	In 2023, our Board adopted an amendment to our Bylaws to provide as an exclusive forum (i) the Delaware Court of Chancery for certain types of actions and claims (including derivative actions, actions asserting a claim of breach of fiduciary duty and actions against us arising pursuant to the Delaware General Corporation Law or our organizational documents) and (ii) the federal district courts of the United States for claims arising under the Securities Act of 1933, as amended (the Securities Act), in each case subject to certain limitations.	2023	Our Board believes this provision is in the best interest of Axon and its shareholders. First, designating a forum in which certain claims can be brought promotes the efficient resolution of such claims and reduces the likelihood of duplicative lawsuits being brought in multiple jurisdictions.

Related Party Transactions

The document mentions that Mark W. Kroll, Ph.D., who is not standing for re-election to the Board, provides consulting services to the Company, with expenses related to these services being approximately $114,000 for the year ended December 31, 2023.

Stakeholder Impact

Shareholders are impacted by the company's financial performance, strategic decisions, and corporate governance practices.
Employees are affected by compensation plans, benefits, and opportunities for professional development.
Customers (law enforcement agencies) benefit from the company's technology solutions that enhance their capabilities and promote safer interactions with the communities they serve.
Communities benefit from the company's efforts to reduce violence and improve public safety.
Suppliers and creditors are impacted by the company's financial stability and ability to meet its obligations.

Next Steps

Shareholders will vote on the election of directors, approval of stock incentive plans, and ratification of the appointment of the independent registered public accounting firm at the Annual Meeting on May 10, 2024.
The company will continue to invest in technology, training, and data initiatives to achieve its moonshot goal of reducing gun-related deaths.
Axon will focus on scaling the Apollo Alliance program nationally to hit its full goal by 2033.

Key Dates

Date	Description
2001	Initial Public Offering (IPO)
2003	Dr. Mark Kroll joined the Board
2003	Michael Garnreiter joined the board of Knight-Swift Transportation Holdings Inc.
2005	Adriane Brown served as President and CEO of Honeywell Transportation Systems
2006	Michael Garnreiter joined the Board
2007	Michael Garnreiter joined the board of Amtech Systems, Inc.
2009	Joshua M. Isner joined Axon
2010	Hadi Partovi joined the Board
2016	Matthew R. McBrady joined the Board
2017	Julie A. Cullivan joined the Board
2018	The Company discontinued its long-term performance-based RSU grants to NEOs
2018	The Board adopted stock ownership guidelines in December 2018.
2019	The Company entered into revised employment agreements with Mr. Isner and Mr. Kunins
2020	Adriane Brown joined the Board
2022	Brittany Bagley joined Axon
2023	Erika Ayers Badan, Graham Smith and Jeri Williams enhance the skills and expertise needed to effectively oversee our Companys strategy, in the short-term and in the years to come.
2023	The Board updated its Corporate Governance Guidelines to establish limits on the number of boards on which our directors may serve.
2023	The Board updated its Corporate Governance Guidelines to implement formal term limits for directors in order to ensure alignment of director qualifications, attributes, skills and experience with the Companys evolving strategy.
2023	We amended our Bylaws to adopt a proxy access provision, which permits a shareholder, or a group of up to 20 shareholders, who own 3% or more of our voting stock continuously for at least three years, to nominate and include in our annual meeting proxy materials director nominees constituting up to the greater of two directors or 20% of the Board, subject to certain conditions and provided that the shareholder(s) and director nominee(s) satisfy all eligibility, procedural and disclosure requirements specified in our Bylaws, including that each director nominee submitted through the proxy access provisions must meet the qualifications to be an independent director.
2023	Our Board adopted an amendment to our Bylaws to provide as an exclusive forum (i) the Delaware Court of Chancery for certain types of actions and claims (including derivative actions, actions asserting a claim of breach of fiduciary duty and actions against us arising pursuant to the Delaware General Corporation Law or our organizational documents) and (ii) the federal district courts of the United States for claims arising under the Securities Act of 1933, as amended (the Securities Act), in each case subject to certain limitations.
2023	The Board adopted stock ownership guidelines in December 2018. NEOs are required to own at least 50,000 shares of the Companys stock.
2023	In accordance with SEC rules and NASDAQ Listing Standards, the Company adopted an incentive compensation recovery policy, effective as of December 1, 2023.
2023	On December 8, 2023, the Company entered into an employment agreement (the CEO Employment Agreement) with Mr. Smith.
2023	On December 8, 2023, the Company entered into a letter agreement (the CEO Letter Agreement) with Mr. Smith, pursuant to which the Company agreed to waive the holding period on shares of Company common stock having a value of approximately $25 million, which Mr. Smith acquired upon exercise of options pursuant to the 2018 CEO Performance Award, so that Mr. Smith could contribute such shares to a charitable fund in 2023.
2023	On October 14, 2023, the Board adopted the Axon Enterprise, Inc. 2024 eXponential Stock Plan (the 2024 Employee XSP or XSP 2.0), which provides for XSU awards to employees (other than our CEO), subject to shareholder approval.
2023	On December 18, 2023, the Compensation Committee approved the grants of XSUs under the 2024 Employee XSP to our NEOs (other than our CEO), effective as of December 22, 2023 and contingent on shareholder approval.
2024	On March 4, 2024, the Board determined to follow the NCG Committees recommendation and appointed Graham Smith as Audit Committee Chair to begin a smooth transition.
2024	The 2024 Annual Meeting of Shareholders (the Annual Meeting) of Axon Enterprise, Inc. (the Company or Axon) will be held at 10:00 a.m. Pacific time on Friday, May 10, 2024.
2024	This proxy statement is first being made available or sent to shareholders on or about March 29, 2024.

Keywords

Axon, revenue, EBITDA, TASER, cloud services, gun violence, body cameras, drones, robotics, AI, law enforcement, public safety

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.